Jane Street’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-25,837
| Closed | -$96.4K | – | 6959 |
|
2024
Q3 | $96.4K | Buy |
+25,837
| New | +$96.4K | ﹤0.01% | 5484 |
|
2024
Q1 | – | Sell |
-23,626
| Closed | -$124K | – | 6464 |
|
2023
Q4 | $124K | Buy |
+23,626
| New | +$124K | ﹤0.01% | 5199 |
|
2023
Q3 | – | Sell |
-47,693
| Closed | -$927K | – | 5866 |
|
2023
Q2 | $927K | Sell |
47,693
-17,184
| -26% | -$334K | ﹤0.01% | 3123 |
|
2023
Q1 | $1.84M | Buy |
64,877
+43,430
| +202% | +$1.23M | ﹤0.01% | 2141 |
|
2022
Q4 | $627K | Buy |
+21,447
| New | +$627K | ﹤0.01% | 3141 |
|
2022
Q3 | – | Sell |
-12,620
| Closed | -$561K | – | 6499 |
|
2022
Q2 | $561K | Buy |
12,620
+3,278
| +35% | +$146K | ﹤0.01% | 3424 |
|
2022
Q1 | $462K | Buy |
9,342
+1,655
| +22% | +$81.8K | ﹤0.01% | 3850 |
|
2021
Q4 | $391K | Buy |
7,687
+2,399
| +45% | +$122K | ﹤0.01% | 3733 |
|
2021
Q3 | $295K | Buy |
+5,288
| New | +$295K | ﹤0.01% | 3995 |
|
2021
Q1 | – | Sell |
-7,900
| Closed | -$368K | – | 5481 |
|
2020
Q4 | $368K | Sell |
7,900
-1,214
| -13% | -$56.6K | ﹤0.01% | 2989 |
|
2020
Q3 | $387K | Buy |
+9,114
| New | +$387K | ﹤0.01% | 2663 |
|
2018
Q2 | – | Sell |
-4,021
| Closed | -$212K | – | 3847 |
|
2018
Q1 | $212K | Buy |
+4,021
| New | +$212K | ﹤0.01% | 2780 |
|
2017
Q3 | – | Sell |
-3,073
| Closed | -$242K | – | 3465 |
|
2017
Q2 | $242K | Buy |
3,073
+420
| +16% | +$33.1K | ﹤0.01% | 2453 |
|
2017
Q1 | $220K | Buy |
+2,653
| New | +$220K | ﹤0.01% | 2470 |
|
2016
Q3 | – | Hold |
0
| – | – | – | 3139 |
|
2016
Q2 | – | Sell |
-5,112
| Closed | -$207K | – | 3050 |
|
2016
Q1 | $207K | Buy |
+5,112
| New | +$207K | ﹤0.01% | 2266 |
|
2015
Q4 | – | Sell |
-6,699
| Closed | -$496K | – | 3114 |
|
2015
Q3 | $496K | Buy |
6,699
+1,372
| +26% | +$102K | ﹤0.01% | 1577 |
|
2015
Q2 | $431K | Sell |
5,327
-2,798
| -34% | -$226K | ﹤0.01% | 1645 |
|
2015
Q1 | $340K | Buy |
+8,125
| New | +$340K | ﹤0.01% | 1670 |
|